Recent 8-K filings for XBIO

Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.

• May 13, 2026 12:05 UTC earnings item 2.02item 9.01

  Xenetic Biosciences Q1 2026 net loss down 49% to $0.5M; royalty revenue up 36% to $0.8M

source · XBIO on sec.gov